.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Chinese Patent Office
Moodys
Baxter
Fuji
McKesson
Fish and Richardson
Dow
Federal Trade Commission
Express Scripts

Generated: December 14, 2017

DrugPatentWatch Database Preview

CAPITAL AND CODEINE Drug Profile

« Back to Dashboard

When do Capital And Codeine patents expire, and what generic alternatives are available?

Capital And Codeine is a drug marketed by Actavis Mid Atlantic, Valeant Pharms Llc, and Carnrick. and is included in three NDAs.

The generic ingredient in CAPITAL AND CODEINE is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.

Summary for CAPITAL AND CODEINE

Drug patent expirations by year for CAPITAL AND CODEINE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Actavis Mid AtlanticCAPITAL AND CODEINEacetaminophen; codeine phosphateSUSPENSION;ORAL085883-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Valeant Pharms LlcCAPITAL AND CODEINEacetaminophen; codeine phosphateSUSPENSION;ORAL086024-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
CarnrickCAPITAL AND CODEINEacetaminophen; codeine phosphateTABLET;ORAL083643-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Julphar
Covington
Mallinckrodt
Deloitte
US Department of Justice
Argus Health
Fuji
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot